Phase 3 Study of Plozasiran in Adults With Hypertriglyceridemia

Clinical trial NCT06347133 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06347133
Sponsor: Arrowhead Pharmaceuticals
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Hypertriglyceridemia

Start date: 2024-05-21
Primary completion: 2026-06-01
Enrollment: 1456

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.